Exploring the Anti-Urolithiatic Potential of White Seeds from Abrus Precatorius Via In Vitro Investigations

Medicinal plants are a valuable aspect of local heritage with global importance, often used as remedies for various health conditions. Their therapeutic properties are linked to a wide variety of complex chemical compounds, particularly secondary metabolites, found in different plant parts. Identifying the specific components responsible for medicinal effects is essential. Phytochemicals, which are abundant in medicinal plants, are generally considered safer and less toxic compared to synthetic alternatives. In line with this understanding, the present research investigates the in vitro anti-urolithiatic potential of white seeds of Abrusprecatorius. The seeds were chosen for their possible role in treating urolithiasis. Phytochemical screening of the plant extract revealed the presence of compounds such as flavonoids, coumarins, saponins, proteins, glycosides, quinones, and tannins.Two In Vitro assays, Crystal Nucleation and Aggregation, were performed, both with and without inhibitors. The study tested various concentrations of plant extracts (50mg/ml, 100mg/ml, 150mg/ml, 200mg/ml, and 250mg/ml) using four solvents: water, ethanol, chloroform, and petroleum ether, to assess their effect on calcium oxalate (CaOX) crystal formation, which is a primary component of kidney stones.Among the extracts tested, the water extract showed the highest inhibition of nucleation (85%) at a concentration of 250mg/ml. Aqueous, ethanol, and chloroform extracts exhibited notable anti-urolithiatic activity across different concentrations. Crystal aggregation was assessed using a spectrophotometer, and the water extract demonstrated the highest inhibition (78%) at the same concentration. Additionally, the chloroform extract showed significant anti-urolithiatic activity.When comparing extracts, the chloroform extract at 500mg/ml was the most effective in inhibiting the growth of calcium oxalate crystals. Overall, the study highlights the potential of Abrusprecatorius white seed extracts in inhibiting calcium oxalate crystal nucleation, aggregation, and growth, suggesting their potential as a treatment for urolithiasis. These results underscore the value of these extracts as promising agents in managing kidney stones